Incubating
skeletal muscle fibers with forskolin, an activator of adenylate cyclase, increases the rate at which nicotinic acetylcholine receptors (AChRs) desensitize when exposed to ACh. Several reports indicate that this is due to the phosphorylation of AChRs by CAMP-dependent protein kinase, but other studies suggest that forskolin interacts with AChRs directly and that second-messenger systems are not required. To help clarify this issue, we studied the effects of forskolin and several other drugs on AChR function in embryonic rat myotubes.
AChR function was studied by recording ACh-induced membrane depolarizations and AChinduced single-channel currents.
Our results indicate that forskolin at low concentrations enhances AChR desensitization through the action of a second messenger, most likely CAMP. An analog of forskolin that is much less effective in activating adenylate cyclase (1,9-dideoxyforskolin) is also much less potent in enhancing desensitization. Forskolin at low concentrations does not alter single-channel conductance or mean channel open time. However, when used at concentrations above 20 NM, forskolin may also exert direct drug effects on AChRs.
Protein phosphorylation appears to be a general mechanism for modulating the functional properties of ion channels (for review, see Kaczmarek and Levitan, 1987) . Although many types of channels are modulated by agents that activate protein kinases, the underlying biochemical mechanisms are poorly understood. In most systems it is not known if kinases act by phosphorylating the channel itself or a separate regulatory protein.
Because it is by far the best characterized chemically-gated ion channel, the nicotinic acetylcholine receptor (AChR) should be useful in clarifying how channel function is modulated by protein phosphorylation. Abundant evidence indicates that the AChR is a phosphoprotein (Gordon et al., 1977; Teichberg et al., 1977; Huganir and Greengard, 1983; Huganir et al., 1984; Miles et al., 1987) . AChRs from Torpedo electric organ are substrates for CAMP-dependent protein kinase (A kinase), protein kinase C, and tyrosine-specific protein kinase. The likely phosphorylation sites have been identified in each case (Huganir et al., 1984) . Although much remains to be learned about the functional significance of AChR phosphorylation, recent studies indicate that phosphorylation by A kinase increases the rate of AChR desensitization. Forskolin and other agents that stimulate CAMP-dependent pathways enhance AChR desensitization (Albuquerque et al., 1986; Middleton et al., 1986) and stimulate AChR phosphorylation (Miles et al., 1987) in rat muscle cells. Furthermore, rapid-flux studies of purified Torpedo AChRs have provided direct evidence linking AChR phosphorylation to an increased rate of desensitization (Huganir et al., 1986) .
In this paper we extend our earlier physiological studies of AChR modulation to the single-channel level. The results indicate that forskolin, a powerful activator of adenylate cyclase, enhances agonist-induced desensitization without significantly changing the properties of individual single-channel currents. It seems likely that forskolin does so by promoting the phosphorylation of AChRs by A kinase. In contrast to results obtained in other systems (Akagi and Kudo, 1985; McHugh and McGee, 1986) we found no indication that forskolin at low concentrations affects AChR function directly.
Materials and Methods
Chemicals. Forskolin and 1,9-dideoxyforskolin were obtained from Calbiochem. Each was prepared as a 10 mM stock in 95% ethanol. L-15 and Dulbecco's Modified Eagle's Medium (DMEM) tissue culture media were obtained from GIBCO. The CAMP analogs b-methylthio-CAMP and 8-(4-chlorophenylthio)-CAMP were obtained from ICN Biochemical and Boehringer Mannheim, respectively. The phosphodiesterase inhibitor RO 20-1724 was a generous gift from Hoffmann-LaRoche. All other chemicals were obtained from Sigma.
Cell cultures. Muscle cultures were prepared with conventional techniques (Rubin, 1985) . Whole leg muscle was removed from rats ranging in age from embryonic day 19 to postnatal day 1. The muscle was minced and incubated for 20 min at 37°C in Ca*+-and Mgz+-free Puck's saline G with 0.05% trypsin. The tissue was pelleted, resuspended in DMEM supplemented with 20% fetal calf serum, and an additional 6 mg/ml glucose, triturated with a Pasteur pipette, and filtered to remove tissue fragments. The cells were preplated for 1 hr to remove fibroblasts, and those that remained in suspension were plated in 35 mm tissue culture dishes (400,00O/dish) containing collagen-coated glass coverslips.
The cultures were fed every 3 d after plating with DMEM supplemented with 10% horse serum, 2% chick embryo extract, and an additional 6 mg/ml glucose. Sometimes 1O-5 M cytosine arabinoside was added to 4-d-old cultures for 24-48 hr to slow the growth of fibroblasts, but in other cases this was unnecessarv. Similar results were obtained in both cases.
Electrophysiology. For each experiment, a coverslip with myotubes was placed in a recording chamber on a Zeiss UEM microscope and viewed at x 500 with a x 40 water-immersion objective. bathed in L-15 medium or a saline solution containing (in mM) 150 NaCl, 3 KCl, 1 MgCl,, 1 CaCl,, 33 glucose, and 10 HEPES (titrated to pH 7.2 with NaOH). In some experiments, TTX (2 @M) was added to stop spontaneous twitching. All experiments were performed at room temperature (2 l-23°C). Ionophoretic assays of ACh sensitivity were made as described in Middleton et al. (1986) . Myotubes were impaled with intracellular electrodes with resistances of -80 MQ when filled with 3 M KCl. Ionophoretic electrodes were similar but were filled with 2 M AChCl. Both electrodes were connected to an Axoclamp 2A amplifier. ACh leakage was minimized with a negative backing current of l-2 nA. Ionophoretic pulses were 2 msec in duration, 5-l 5 nA in amplitude, and were delivered in l-2 set trains at 7 Hz. A laboratory computer (LSI 1 l/73; Digital Equipment Corporation) was used to deliver the pulses, record the responses, and calculate the ACh sensitivity in units of depolarization per unit charge delivered. AChR desensitization was characterized in terms of the decrease in response amplitude between the first and seventh pulses in a train (Fig. 1) .
Single-channel recordings of AChRs were obtained with conventional techniques (Hamill et al., 198 1) as described (Jaramillo and Schuetze, 1988) . The patch pipette was filled with the bath saline solution (less glucose) supplemented with ACh (10 nM-1 mM). In some experiments, the filling solution also contained forskolin at a final concentration of lo-20 PM. The pipette was connected to a List EPC-5 patch-clamp amplifier, and the current output signal was low-pass-filtered at 14 kHz (8-pole Bessell; Frequency Devices, Inc., Haverhill, MA) and digitized by a laboratory computer (LSI 1 l/73). The sampling frequency was usually 5 times the comer frequency of the analog filter.
Single-channel analysis. Measurements of single-channel amplitudes
and distributions of open and closed times were made with a semiautomated procedure based on half-amplitude threshold analysis, as described in detail elsewhere (Jaramillo and Schuetze, 1988) . Events shorter than twice the sampling interval were ignored.
In some experiments we studied the effects of forskolin on the gating properties of AChRs by comparing the open time distributions in the presence and absence of the drug. The interpretation of open times is generally unclear because of the presence of undetected brief closings, and it is therefore usually preferable to characterize events in terms of their burst durations (Colquhoun and Sakmann, 1985) . However, we were forced to use open times rather than burst durations because many of our experiments were done at high agonist concentrations, and under these conditions events are often so frequent that the definition of a burst becomes ambiguous.
Open time distributions were fitted with 1 or 2 exponentials by the method of maximum likelihood. At low agonist concentrations the open time distributions contained 2 exponential components. The amplitude of the faster component decreased with ACh concentration, and at high concentrations (typically 2 10 PM) good fits were obtained with a single exponential (Jaramillo and Schuetze, 1988) . In the experiments reported here, we focused on the slower of the 2 open time components.
The amount of AChR channel activity in a patch was expressed as Np,, where N is the number of channels in the patch and p, is the probability that a channel is open. Np, was defined as I/i, where i is the single-channel current amplitude and I is the mean current during the entire record. Z was measured by fitting a straight line to the baseline (correcting for drift as required) and integrating the area beyond the baseline. In some experiments this procedure was modified to express Np, as a function of time. This was done by calculating a running average of Z over a time window 5-60 set long (see Logothetis et al., 1987) . Np, varied widely between patches in control experiments, even though the recording conditions were apparently identical. Presumably, this was mostly due to variability in the number of AChRs in the patch. We controlled for this by averaging data from several patches for each experimental condition. A related problem was that the mean activity level varied between different platings of myotubes. For example, with 20 WM ACh in the patch pipette Np, varied from a low of 0.1 + 0.1 in one group of cultures (mean * SD, n = 8 patches) to an extreme value of 2.3 * 1.8 in another (n = 9 patches). This problem was circumvented by obtaining the control and test patches for each experiment from the same cultures and often from the same myotubes.
Results

Forskolin enhances AChR desensitization in rat myotubes
We assayed AChR desensitization in rat myotubes by measuring the membrane depolarizations evoked by a train of ACh pulses. In untreated myotubes, each pulse in a 7 Hz train evoked about the same response amplitude, indicating little or no desensitization (Fig. 1A) . After the myotubes were exposed to a combination of 10 WM forskolin and the phosphodiesterase inhibitor RO 20-1724, the initial response amplitude was little changed, but successive responses fell by 65% within 1 set (Fig. 1B) . This indicates that forskolin enhanced the rate of agonist-induced AChR desensitization without affecting the ability of AChRs to be activated by ACh initially (but see below). ACh sensitivity recovered fully within less than a minute after the pulses were discontinued, and application ofa second pulse train again evoked a rapid fall in response amplitude (not shown). The drug effects reversed fully after washout (Fig. 1 C) . These results are similar to those reported previously in studies of rat soleus muscles (Middleton et al., 1986) .
Evidence that forskolin acts on AChRs via the CAMP pathway If forskolin acts on AChRs via the CAMP pathway, the drug should enhance desensitization with a concentration dependence and time course consistent with its activation of adenylate cyclase. We tested this idea with the ionophoretic assay. Seamon et al. (198 1, 1984) reported that forskolin activates hormonally responsive adenylate cyclase with half-maximal effects at 5-10 PM. We found that forskolin enhances AChR desensitization at concentrations as low as l-2 PM and with halfmaximal effects at about 6 KM ( Fig. 2) , in good agreement with the biochemical data. Concentrations higher than 30 FM were not tested because at these drug levels the ACh sensitivity appeared to be lower than normal. That is, even the initial response to a train of ACh pulses was small, and it was impossible to quantify desensitization with this approach. The apparent decrease in ACh sensitivity may reflect an additional effect of forskolin at high concentrations.
Alternatively, it is possible that the number of activable AChRs is unchanged, but desensitization is so rapid that many AChRs become inactive during the rising phase of the first response.
Forskolin activates adenylate cyclase rapidly and reversibly (Seamon et al., 198 1, 1984) . To determine if the drug's effects on AChRs are also rapid and reversible, we studied the same membrane sites before, during, and after treating myotubes with 10 FM forskolin. We found that the level of desensitization reached a plateau within minutes of drug addition, and recovery took place within minutes after drug washout (Fig. 3) . Again, the results are consistent with the biochemical data.
Several other observations support the idea that forskolin enhances desensitization by raising intracellular levels of CAMP. AChR desensitization was enhanced by the phosphodiesterase inhibitor RO 20-1724 used alone and by 2 analogs of CAMP ( Fig. 1D and Table 1 ). The CAMP analog 8-bromo-CAMP proved ineffective (Table l) , but this has been observed in other systems thought to be regulated by CAMP (Dunlap, 1985) . Furthermore, in a separate series of experiments using an ineffective concentration of RO 20-1724, the effects of 1 WM forskolin were enhanced 4-fold. The percentage decrease in the response amplitude after 7 pulses of ACh with 1 PM forskolin alone was 2 + 4 (mean f SD, n = 6), whereas in combination with RO 20-1724, it was 9 f 7 (n = 10).
Possible direct eflect of forskolin on AChR channels In some systems forskolin apparently alters channel activity via a direct action, possibly open channel block, that is independent of its stimulation of adenylate cyclase (Akagi and Kudo, 1985; McHugh and McGee, 1986; Grassi et al., 1987) . We tested for direct actions on myotube AChRs by comparing the effects of forskolin and 1,9-dideoxyforskolin, a forskolin analog that does not stimulate adenylate cyclase (Seamon et al., 1984) . These Time (minutes) Figure   3 . Time course of forskolin-stimulated increase in desensitization. AChR desensitization was measured at zero time from a myotube in control medium, and then the culture was bathed in 10 PM forskolin and 35 FM RO 20-1724. The same myotube was assayed repeatedly at the indicated times. After 1 hr the drugs were washed out (arrow) and the myotube was assayed again. The symbols indicate the mean * SEM of 4 experiments. experiments were done in the absence of the phosphodiesterase inhibitor RO 20-1724 because, as just noted, they partially mimic the effects of forskolin.
When used at 10 PM, forskolin markedly enhanced AChR desensitization but 1,9-dideoxyforskolin did not (Fig. 4, A and  B) . This is consistent with the idea that forskolin acts via CAMP. However, both drugs enhanced desensitization when used at 20 FM, although forskolin was clearly more potent (Fig. 4, C and  D) . In this experiment, 20 WM forskolin also appeared to lower ACh sensitivity (Fig. 40) . As discussed above, this may reflect rapid desensitization rather than a true loss of sensitivity.
These data indicate that forskolin may act on AChRs in 2 ways. At low concentrations (5 10 FM), it apparently acts primarily by stimulating adenylate cyclase; at higher concentra- tions, the drug may also act on AChR channels directly. Consistent with this idea, previous work has indicated that 100 PM forskolin appears to act as a modest open channel blocker of AChRs (Middleton et al., 1986) . We turned to single-channel recordings to help distinguish direct and indirect actions of forskolin more cleanly.
EJects of forskolin on AChR activity at the single-channel level AChR activity in cell-attached patches was quantified in terms of Np,, where N is the number of AChR channels in the patch and p, is the probability that any particular channel is open (see Materials and Methods). Potential direct effects were examined by adding forskolin to the patch pipette but omitting it from the bath. This exposes AChRs to forskolin but minimizes drug entry into the cell. We found no obvious effects of pipetteapplied forskolin on AChR activity. Records obtained with the drug were indistinguishable from control records (Fig. 5, A and  9 .
A more rigorous, quantitative comparison was made using paired recordings from 8 different myotubes. In each case, one cell-attached patch was assayed with ACh alone (10, 20, or 100 FM) and another was studied with the same concentration of ACh in combination with forskolin (1 O-20 PM). Np, averaged 0.11 f 0.12 (mean f SD) when forskolin was in the pipette and 0.11 + 0.10 when it was not (Fig. 6) . Forskolin also had no effect on the mean open time or unitary conductance ofAChR channels (Table 1 and Middleton et al., 1986) . These data indicate that the forskolin-enhanced desensitization in the ionophoretic experiments is not likely to be the result of a direct action on AChRs.
Indirect forskolin actions, possibly mediated by CAMP, were studied by adding the drug to the bath but omitting it from the pipette filling solution. This exposes virtually the entire cell to C Figure 5 . Single-channel records from myotubes before and after exposure to forskolin. A, AChR channel openings recorded from a control myotube in the absence of forskolin. B, Record obtained from another myotube on the same coverslip with 10 PM forskolin in the patch pipette. C, Record obtained from a third myotube on the same coverslip 20 min after forskolin was added to the bath (final concentration, 10 ELM). All 3 records were obtained from cell-attached patches with 10 I.~M ACh in the pipette at approximately the same time following the formation of each patch. The records were low-pass-filtered at 1 kHz, and the patch was hyperpolarized 20 mV from rest. Calibration bars, 500 msec, 3.5 pA.
forskolin, as in the ionophoretic experiments. However, the AChRs within the patch are not directly exposed to forskolin once the patch is formed since the pipette filling solution contains no drug. Inclusion of forskolin in the bath (but not in the pipette) resulted in a dramatic inhibition of AChR activity (Fig.  5C ). In the experiment shown here, the patch was obtained 20 min after forskolin addition. Similar results were obtained after shorter exposures to forskolin, the shortest being 5 min (data not shown). Np, averaged 0.27 -t 0.30 with myotubes in control medium (n = 26 patches, 20 PM ACh). When the same cultures were studied in a bath containing lo-20 WM forskolin, Np, was only 0.0075 +-0.0090 (n = 12 patches, 20 WM ACh), a 36-fold decrease (Fig. 6) .
In contrast, bath applied 1,9-dideoxyforskolin had little effect on AChR activity when the same experimental protocol was used. The average Np, from 11 different myotubes was 0.18 + 0.26 before exposure to the drug. After incubating the same cells in 10 FM 1,9-dideoxyforskolin Np, averaged 0.07 + 0.09 (Fig.  6 ). This does not represent a significant decrease in AChR activity (Student's t test and the Wilcoxon signed-rank test; Snedecor and Cochran, 1967) .
In the experiments illustrated in Figures 5 and 6 , myotubes were incubated with the drugs for at least several minutes prior to seal formation, and therefore, different membrane patches were used for controls and experiments. We also tried recording from the same patch before and after adding forskolin to the bath. The results were unpredictable (Fig. 7) . Sometimes forskolin addition was associated with a sharp drop in AChR activity, indicating an enhancement of desensitization, but at other times, the drug seemed to be without effect. We suspect that membrane distortions introduced by seal formation may interfere with second-messenger effects (see Discussion).
In summary, forskolin strongly decreased AChR activity when added to the bath but not when added to the patch pipette filling solution. Bath-applied 1,9-dideoxyforskolin did not decrease AChR activity significantly. Taken together, these results strongly suggest that forskolin acts on AChRs via a second messenger, presumably CAMP, diffusing through the cytoplasm.
Forskolin appears to enhance AChR desensitization selectively Records obtained in the presence of bath-applied forskolin seemed to differ from control records only in the frequency of channel openings and not in the characteristics of individual ACh-evoked currents. This was confirmed by more careful analysis. Bath-applied forskolin had virtually no effect on either single-channel conductance or mean channel open time ofAChRs at any ACh concentration tested (Fig. 8, Table 2 ; also compare Fig. 9, B and D) . These data argue further against a channelblocking mechanism and are consistent with the idea that forskolin enhances AChR desensitization selectively.
One prediction of this hypothesis is that forskolin's effectiveness should depend on the concentration of ACh. The drug should strongly decrease AChR activity at high, desensitizing ACh concentrations but have little effect at low agonist levels. In contrast, if forskolin silences AChRs directly rather than enhances agonist-induced desensitization, then it should decrease AChR activity at all ACh concentrations. This was tested by studying forskolin's activity with various concentrations of ACh in the patch pipette.
In the single most complete experiment, 4 different cell-attached patches on the same myotube were studied under different conditions. The culture was first bathed in control medium and 2 patches were assayed at different ACh concentrations. Much more AChR activity was evoked by ACh at 100 PM (Np, = 0.58; Fig. 9B ) than at 0.1 PM (Np, = 0.06; Fig. 9A) . The culture was then bathed in 10 FM forskolin and 2 additional patches were obtained from the same cell. The activity level at 0.1 WM ACh was the same as control (Np, = 0.07; Fig. 9C ) but that at 100 FM ACh was much lower (Np, = 0.09; Fig. 9D ). In short, forskolin inhibited channel activity only at the higher, desensitizing ACh concentration.
Further studies confirmed and extended these results. Np, values obtained in the absence or presence of forskolin with nondesensitizing ACh concentrations (0.0 1-O. 1 MM) in the pipette were 0.02 -t 0.02 (n = 11) and 0.04 f 0.06 (n = 14), respectively. In contrast, when the pipette contained desensitizing concentrations of ACh (l-l 00 PM), the Np, values before and after forskolin treatment were 1.2 f 1.6 (n = 36) and 0.04 f 0.06 (n = 24), respectively. This represents a 30-fold decrease in channel activity and supports the view that the drug does not silence AChRs directly but, rather, increases their susceptibility to agonist-induced desensitization.
Discussion
Forskolin enhances AChR desensitization As reported previously for AChRs at rat soleus endplates (Middleton et al., 1986 ) the major action of forskolin on myotube AChRs appears to be a marked enhancement of agonist-induced desensitization. Forskolin promoted a progressive, rapid decrease in the amplitude of responses evoked by a train of ACh pulses. However, except when the drug was used at concentrations higher than about 20 PM, forskolin did not reduce the amount of depolarization evoked by the first ACh pulse in a train. This indicates that forskolin did not desensitize AChRs directly nor decrease their initial response to agonist via some other mechanism. Rather, it apparently increased the rate at which they desensitized when exposed to ACh.
The single-channel data support this interpretation. Forskolin treatment effected a striking decrease in the amount of channel activity in cell-attached patches, but the openings that did occur were unchanged in their visual appearance, unitary conductance, and mean open time. Furthermore, forskolin decreased channel activity only at ACh concentrations of 1 PM and above; at lower ACh concentrations, experimental and control records were indistinguishable. This supports the idea that forskolin promotes the susceptibility of AChRs to ACh-induced desensitization.
Desensitization of nicotinic AChRs occurs in 2 distinct phases: fast and slow (Sakmann et al., 1980; Feltz and Trautmann, 1982) . When exposed to high concentrations of ACh, AChRs desensitize on a time scale of tenths of seconds to seconds. If ACh is removed quickly, recovery from desensitization is also rapid. Prolonged application of ACh, even at low doses, pushes AChRs into a second desensitized state characterized by on and off rates roughly IO-fold slower. We have not characterized which of these 2 processes is modulated by forskolin, but the rapid rates of onset and offset suggest that it is the faster one. In principle, a definitive answer could be obtained by analyzing the kinetics of clusters of openings in single-channel records, but our attempts to do so were unsuccessful. Even with high concentrations of ACh (100 KM), clusters of AChR channel openings were not as distinct as described in frog muscle (Sakmann et al., 1980) .
Mechanism of forskolin S action
An alternative explanation for many of our results is that forskolin treatment does not modulate AChR desensitization via a second messenger but, instead, blocks open channels directly so that they become nonconducting. If the blocked state is longlived, responses to a train of ACh pulses would become progressively smaller as more and more channels become nonconducting, as we observed. In addition, blocking would explain the decreased activity in our single-channel records.
A key feature of this model is that forskolin is postulated to act by interacting with AChRs directly. This has been reported to occur in other systems (Akagi and Kudo, 1985; McHugh and McGee, 1986; Grassi et al., 1987) . To some extent, forskolin may also affect myotube AChRs directly. In the ionophoretic assay, 20 PM 1,9-dideoxyforskolin partially mimicked the action of forskolin, even though it does not activate adenylate cyclase. Furthermore, previous results showed that forskolin at 100 PM decreases channel open time slightly, consistent with a moderate channel-blocking activity (Middleton et al., 1986) .
On the other hand, at lower drug concentrations, actions mediated by a second messenger appear to be much more important than direct drug effects. Forskolin at 10 PM effected a striking decrease in the response of myotubes to a train of ACh pulses, whereas 10 FM 1,9-dideoxyforskolin did not. Albuquerque et al. (1986) have reported similar results in a different system using a lower concentration of forskolin and the same inactive analog. Stronger evidence for a second-messenger mechanism comes from single-channel experiments. Placing lo-20 PM forskolin in the patch pipette, which should permit direct effects, had no detectable effect on the level of AChR channel activity, open time, or conductance. In contrast, placing 10 PM forskolin in the bath (and omitting it from the recording pipette) effected a 36-fold decrease in the amount of AChR channel activity in cell-attached patches. This argues strongly for the involvement of a second messenger in forskolin's actions.
The most likely second messenger is CAMP. Forskolin is known to elevate intracellular levels of CAMP by activating adenylate cyclase, and it does so over the same concentration range with which it enhances AChR desensitization (Seamon et al., 198 1, 1984) . Other observations further support this view. The drug was more effective when combined with a phosphodiesterase inhibitor than when used alone, and the phosphodiesterase in- hibitor RO 20-1724 and 2 analogs ofcAMP mimicked the effects of forskolin.
An attractive mechanism for forskolin's actions is that it enhances desensitization by stimulating the phosphorylation of myotube AChRs by CAMP-dependent protein kinase (A kinase). Recently, Miles et al. (1987) studied the effects of forskolin on the phosphorylation of AChRs in rat myotubes in vitro under conditions similar to those used here. Incubating the cultures in a combination of 20 PM forskolin and 35 /IM RO 20-1724 stimulated the phosphorylation of the AChR &subunit 20-fold over basal levels. The effect was rapid and dose dependent. At 20 WM forskolin, a half-maximal response was observed within 5 min. When assayed under steady-state conditions, the cultures exhibited half-maximal phosphorylation at 8 PM forskolin. Thus, forskolin stimulates AChR phosphorylation and enhances desensitization with a similar time course and concentration dependence. This interpretation agrees with the conclusions of Huganir et al. (1986) , who found a direct link between phosphorylation and desensitization rate in Torpedo AChRs.
Forskolin also stimulates phosphorylation of the AChR a-subunit in rat myotubes. This effect occurs more slowlyhalf-maximal phosphorylation after 30 min (Miles et al., 1987) than the enhanced desensitization reported here. However, it does correlate temporally with a forskolin-stimulated increase in the decay rate of miniature endplate currents in rat soleus muscles (Middleton et al., 1986) . Because this decay rate is directly related to channel lifetime, this suggests that phosphorylation of the AChR a-subunit may decrease the mean channel open time. However, in the current experiments we found no evidence for a change in AChR channel open time even after prolonged (> 1 hr) exposure to forskolin.
One possibility is that phosphorylation of the AChR a-subunit causes a further increase in the desensitization rate, not et al. (Middleton et al., 1986) . In this view, at the high ACh concentration (ca. 1 mM) present during synaptic transmission, AChRs desensitize so fast that endplate currents decay more rapidly. In principle, this hypothesis could be tested in single-channel recordings by using an ACh concentration as high as that found in the synaptic cleft. We attempted to do this, but our results were confounded by the channel-blocking activity of high concentrations of ACh (Ogden and Colquhoun, 1985) . Channel block would not be a problem during synaptic transmission because the ACh pulse is so brief (Magleby and Stevens, 1972; Land et al., 1984) .
Effect of seal formation on forskolin treatment
Although bath-applied forskolin was very effective in decreasing AChR channel activity in pretreated cultures, it was much less effective when added to the bath after cell-attached patches were formed. One could argue that the crucial feature of pretreatment is some type of direct interaction between forskolin and AChRs that remains stable after pat+ formation.
This seems unlikely. The rapid reversibility of forskolin's effects (Fig. 3) suggests that any drug associated with AChRs in the patch should wash out quickly after seal formation.
Furthermore, forskolin was ineffective when added to the patch pipette filling solution.
It seems more likely that seal formation prevented the phosphorylation of AChRs within the patch by A kinase. One possibility is that the Q-like shape of the patch hindered access of kinase to the AChRs. Alternatively, seal formation may have inhibited phosphorylation by disrupting either the structure of the patch membrane or its association with the underlying cytoskeleton. A similar effect has been noted by others (Strong et al., 1987) . After treatment with agents that activate protein kinase C (phorbol esters), Aplysia bag cell neurons express a type of calcium channel that is not seen in control cells. These channels are not detected when the activators are added to the bath after seal formation.
Furthermore, phorbol esters are ineffective when added to the pipette filling solution but omitted from the bath. Taken together with our data, these results suggest that seal formation may interfere with the modulation of ion channels by second-messenger systems.
